Get Quotes

Market Menu

INCOME STATEMENTS-Aarti Drugs Ltd.

You can view the income statements for the last 5 years.

BSE

Feb 22
535.80 +4.75 (+ 0.89%)
Volume 5719
Prev. Close 531.05
Open Price 533.05
Today's Low / High
533.00
     
538.90
Bid Price(Qty.) 0.00 (0)
Open Pr.(Qty.) 0.00 (0)
52 Wk Low / High
310.80
     
645.00

NSE

Feb 22
535.65 +2.20 (+ 0.41%)
Volume 108378
Prev. Close 533.45
Open Price 536.30
Today's Low / High
533.00
     
538.90
Bid Price(Qty.) 0.00 (0)
Open Pr.(Qty.) 0.00 (0)
52 Wk Low / High
313.90
     
645.75
ISIN No INE767A01016 Market Cap. ( Rs. in Cr. ) 4924.50 P/BV 4.13 Book Value ( Rs. ) 129.63
BSE Code 524348 52 Week High/Low ( Rs. ) 646/314 FV/ML 10/1 P/E(X) 29.61
NSE Code AARTIDRUGSEQ Book Closure 06/02/2024 EPS ( Rs. ) 18.09 Div Yield (%) 0.19
( Rs. in Crs. )
ParticularsMar 23Mar 22Mar 21Mar 20Mar 19
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]2716.052488.652154.781806.091560.94
Total Operating Revenues2716.052488.652154.781806.091560.94
      
Other Income2.1911.324.531.482.41
Total Revenue2718.252499.962159.301807.571563.35
      
EXPENSES     
Cost Of Materials Consumed1768.971666.361221.521141.92998.90
Purchase Of Stock-In Trade121.29108.57111.2488.3244.25
Operating And Direct Expenses334.09295.98233.43222.87187.29
Changes In Inventories Of FG,WIP And Stock-In Trade-1.75-86.08-11.72-51.2816.82
Employee Benefit Expenses92.0282.8180.5069.3660.92
Finance Costs33.2920.7522.9633.7339.96
Depreciation And Amortisation Expenses50.3250.0549.8848.7542.56
Other Expenses95.8391.5882.7173.0945.39
Total Expenses2494.072230.011790.521626.751436.09
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax224.18269.96368.79180.82127.26
      
Exceptional Items0.000.000.224.473.77
Profit/Loss Before Tax224.18269.96369.01185.29131.02
      
Tax Expenses-Continued Operations     
Current Tax58.8669.7493.0046.0433.72
Less: MAT Credit Entitlement0.000.00-0.080.000.08
Deferred Tax-1.03-4.78-4.46-9.458.71
Tax For Earlier Years0.000.000.007.30-1.08
Total Tax Expenses57.8264.9688.6243.8941.27
Profit/Loss After Tax And Before ExtraOrdinary Items166.36205.00280.40141.4089.75
      
Profit/Loss From Continuing Operations166.36205.00280.40141.4089.75
      
Profit/Loss For The Period166.36205.00280.40141.4089.75
      
Minority Interest-0.050.040.010.000.00
Consolidated Profit/Loss After MI And Associates166.31205.04280.41141.4089.75
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)17.9722.1230.0960.5738.48
Diluted EPS (Rs.)17.9722.1230.0960.5738.48
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend9.269.2623.306.992.36
Tax On Dividend0.000.000.001.440.48
ParticularsMar 23
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]2716.05
Total Operating Revenues2716.05
Other Income2.19
Total Revenue2718.25
EXPENSES 
Cost Of Materials Consumed1768.97
Purchase Of Stock-In Trade121.29
Operating And Direct Expenses334.09
Changes In Inventories Of FG,WIP And Stock-In Trade-1.75
Employee Benefit Expenses92.02
Finance Costs33.29
Depreciation And Amortisation Expenses50.32
Other Expenses95.83
Total Expenses2494.07
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax224.18
Exceptional Items0.00
Profit/Loss Before Tax224.18
Tax Expenses-Continued Operations 
Current Tax58.86
Less: MAT Credit Entitlement0.00
Deferred Tax-1.03
Tax For Earlier Years0.00
Total Tax Expenses57.82
Profit/Loss After Tax And Before ExtraOrdinary Items166.36
Profit/Loss From Continuing Operations166.36
Profit/Loss For The Period166.36
Minority Interest-0.05
Consolidated Profit/Loss After MI And Associates166.31
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)17.97
Diluted EPS (Rs.)17.97
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend9.26
Tax On Dividend0.00